Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Navelbine|DRUG: Docetaxel
Sponsor: Zhejiang Cancer Hospital